Cambridge
United Kingdom
112
2026-04-09
The entities that hold a legal rights for patent applications filed by inventor Lee E-Chiang:
E-Chiang Lee from Cambridge, GB has applied for patents for these inventions. The list has both pending applications and granted patents:
ANTAGONIST ANTI-CD7 ANTIBODIES
#2 | 2026-03-12TIGIT ANTIBODIES, ENCODING NUCLEIC ACIDS AND METHODS OF USING SAID ANTIBODIES IN VIVO
#3 | 2026-02-19MULTISPECIFIC ANTIBODY WITH COMBINATION THERAPY FOR IMMUNO-ONCOLOGY
#4 | 2024-10-17MULTISPECIFIC ANTIBODIES FOR IMMUNO-ONCOLOGY
#5 | 2024-06-20METHODS, CELLS & ORGANISMS
#6 | 2024-06-06THERAPEUTIC INHIBITORS OF GDF15 SIGNALLING
#7 | 2024-05-16ANTI-ICOS ANTIBODIES
#8 | 2024-02-22Animal Models and Therapeutic Molecules
#9 | 2023-10-05MULTISPECIFIC ANTIBODIES FOR IMMUNO-ONCOLOGY
#10 | 2023-08-31Animal Models and Therapeutic Molecules
#11 | 2023-08-24Animal Models and Therapeutic Molecules
#12 | 2023-07-20Animal Models and Therapeutic Molecules
#13 | 2023-06-22MULTISPECIFIC ANTIBODIES FOR IMMUNO-ONCOLOGY
#14 | 2023-06-22TIGIT ANTIBODIES, ENCODING NUCLEIC ACIDS AND METHODS OF USING SAID ANTIBODIES IN VIVO
#15 | 2023-05-25ANIMAL MODELS AND THERAPEUTIC MOLECULES
#16 | 2023-05-25ANIMAL MODELS AND THERAPEUTIC MOLECULES
#17 | 2023-02-16EXPRESSION VECTOR PRODUCTION AND HIGH-THROUGHPUT CELL SCREENING
#18 | 2022-12-22ANTI-ICOS ANTIBODIES
#19 | 2022-12-01ANTI-ICOS ANTIBODIES
#20 | 2022-10-13ANTAGONISTS ANTI-CD7 ANTIBODIES
#21 | 2022-09-15Animal models and therapeutic molecules
#22 | 2022-03-03FIXAXFX BISPECIFIC ANTIBODY WITH COMMON LIGHT CHAIN
#23 | 2022-02-17ANTAGONISTS
#24 | 2022-01-06MANIPULATION OF IMMUNOGLOBULIN GENE DIVERSITY AND MULTI-ANTIBODY THERAPEUTICS
#25 | 2021-12-23ANTIGEN-BINDING MOLECULES COMPRISING UNPAIRED VARIABLE DOMAINS
#26 | 2021-07-08Animal models and therapeutic molecules
#27 | 2021-04-08FIXaxFX bispecific antibody with common light chain
#28 | 2021-03-18ANIMAL MODELS AND THERAPEUTIC MOLECULES
#29 | 2020-12-03Animal Models and Therapeutic Molecules
#30 | 2020-11-12Animal Models and Therapeutic Molecules
#31 | 2020-11-12Animal Models and Therapeutic Molecules
#32 | 2020-10-29Animal Models and Therapeutic Molecules
#33 | 2020-10-08Antibodies, variable domains and chains tailored for human use
#34 | 2020-10-08Antibodies, Variable Domains and Chains Tailored for Human Use
#35 | 2020-08-27TRANSGENIC NON-HUMAN VERTEBRATE FOR THE IN VIVO PRODUCTION OF DUAL SPECIFICITY IMMUNOGLOBULINS OR HYPERMUTATED HEAVY CHAIN ONLY IMMUNOGLOBULINS
#36 | 2020-07-09CELLS, VERTEBRATES, POPULATIONS & METHODS
#37 | 2020-07-02Transgenic Animals
#38 | 2020-06-25FIXaxFX bispecific antibody with common light chain
#39 | 2020-05-14Bispecific antibodies for factor IX and factor X
#40 | 2020-04-30TIGIT antibodies, encoding nucleic acids and methods of using said antibodies in vivo
#41 | 2019-11-07Methods, cells and organisms
#42 | 2019-10-31Anti-ICOS antibodies
#43 | 2019-10-31Animal models and therapeutic molecules
#44 | 2019-10-03Expression vector production and high-throughput cell screening
#45 | 2019-10-03ANIMALS, CELLS, LIGANDS, POLYPEPTIDES & METHODS
#46 | 2019-06-13Animal models and therapeutic molecules
#47 | 2018-10-18Animal models and therapeutic molecules
#48 | 2018-10-18Transgenic Animals
#49 | 2018-10-04Chimaeric Surrogate Light Chains (SLC) Comprising Human VpreB
#50 | 2018-03-08Anti-ICOS antibodies
#51 | 2018-02-01ANTIBODIES, VARIABLE DOMAINS & CHAINS TAILORED FOR HUMAN USE
#52 | 2017-12-14Animal models and therapeutic molecules
#53 | 2017-11-09Antibodies, variable domains and chains tailored for human use
#54 | 2017-10-26SELECTIVE NAV PROTEIN BINDERS
#55 | 2017-09-28METHODS, CELLS & ORGANISMS
#56 | 2017-05-18Animal models and therapeutic molecules
#57 | 2017-04-20Animal Models and Therapeutic Molecules
#58 | 2017-04-13Animal models and therapeutic molecules
#59 | 2017-04-13Animal Models and Therapeutic Molecules
#60 | 2017-04-13Animal Models and Therapeutic Molecules
#61 | 2017-04-13ANIMAL MODELS AND THERAPEUTIC MOLECULES
#62 | 2017-04-13Animal Models and Therapeutic Molecules
#63 | 2017-04-06Animal models and therapeutic molecules
#64 | 2017-04-06ANIMAL MODELS AND THERAPEUTIC MOLECULES
#65 | 2017-03-23ANIMAL MODELS AND THERAPEUTIC MOLECULES - Track 1
#66 | 2017-03-16ANIMAL MODELS AND THERAPEUTIC MOLECULES
#67 | 2017-02-23ANIMAL MODELS AND THERAPEUTIC MOLECULES
#68 | 2016-12-08Transgenic Animals
#69 | 2016-12-01Animal models and therapeutic molecules
#70 | 2016-12-01ANIMAL MODELS AND THERAPEUTIC MOLECULES
#71 | 2016-09-08Methods, Cells & Organisms
#72 | 2016-09-08Methods, Cells & Organisms
#73 | 2016-09-01Animal models and therapeutic molecules
#74 | 2016-08-04Animal models and therapeutic molecules
#75 | 2016-07-21Expression vector production and high-throughput cell screening
#76 | 2016-07-21Methods, Cells & Organisms
#77 | 2016-06-23Methods, Cells & Organisms
#78 | 2016-06-16Animal models and therapeutic molecules
#79 | 2016-06-02Animal Models and Therapeutic Molecules
#80 | 2016-02-18ANIMAL MODELS AND THERAPEUTIC MOLECULES
#81 | 2015-11-26Animal models and therapeutic molecules
#82 | 2015-05-14Transgenic non-human vertebrate for the in vivo production of dual specificity immunoglobulins or hypermutated heavy chain only immunoglobulins
#83 | 2015-04-23Animal Models and Therapeutic Molecules
#84 | 2015-03-19METHODS, CELLS & ORGANISMS
#85 | 2015-02-05Animal models and therapeutic molecules
#86 | 2015-02-05Manipulation of immunoglobulin gene diversity and multi-antibody therapeutics
#87 | 2015-01-29Human VpreB & Chimaeric Surrogate Light Chains in Transgenic Non-Human Vertebrates
#88 | 2015-01-29Animals, repertoires and methods
#89 | 2014-12-04Chimaeric surrogate light chains (SLC) comprising human VpreB
#90 | 2014-11-06Transgenic Animals
#91 | 2014-11-06Antibodies, variable domains and chains tailored for human use
#92 | 2014-11-06Transgenic Non-Human Assay Vertebrates, Assays and Kits
#93 | 2014-10-30Transgenic Non-Human Assay Vertebrates, Assays and Kits
#94 | 2014-10-30ANIMALS, REPERTOIRES & METHODS
#95 | 2014-09-18Animal models and therapeutic molecules
#96 | 2014-07-31Manipulation of immunoglobulin gene diversity and multi-antibody therapeutics
#97 | 2014-07-17ANIMAL MODELS AND THERAPEUTIC MOLECULES
#98 | 2014-07-17ANIMAL MODELS AND THERAPEUTIC MOLECULES
#99 | 2014-06-26ANIMAL MODELS AND THERAPEUTIC MOLECULES
#100 | 2014-05-29ANIMAL MODELS AND THERAPEUTIC MOLECULES
94827 ⎘